MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. Zhan Y, Guo J, Yang W, Goncalves C, et al. J Clin Invest 2024;134:e181338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhan Y, Guo J, Yang W, Goncalves C, et al. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. J Clin Invest 2024;134:e181338.
PMID: 38618965